2026 NPPES data Pulmonary Disease Physician NPI 1417063603 M.D.
Verify on CMS →

RAFFI CALIKYAN, M.D.

Pulmonary Disease Physician in BRISTOL, Rhode Island. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
6K
Medicare Part D claims · 633 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$2.5K
116 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

RAFFI CALIKYAN, M.D. filed 5,741 Medicare Part D claims in 2023 as a Pulmonary Disease Physician in BRISTOL, Rhode Island, prescribing 59% generic.

6K
Part D claims, 2023
59%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RAFFI CALIKYAN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

5,741 Top 5% higher than 95% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). Below this entry. 1,400–1,600: 21,710 prescribers (2%). Below this entry. 1,600–1,800: 19,072 prescribers (1%). Below this entry. 1,800–2,000: 16,451 prescribers (1%). Below this entry. 2,000–2,200: 213,991 prescribers (16%). This entry sits in this band. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

RAFFI CALIKYAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RAFFI CALIKYAN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/22/2006

NPI 1417063603

Primary specialty

Pulmonary Disease Physician

Mid-sized

9,271 US NPIs in this specialty

Medicare Part D claims

5,741 294% vs specialty avg

2023 prescription claims

Specialty avg: 1,457

Specialty distribution in Rhode Island

How Pulmonary Disease Physician compares to other specialties among Rhode Island providers

Rhode Island providers

Pulmonary Disease Physician share within Rhode Island

1. Pulmonary Disease Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pulmonary Disease Physician share within Rhode Island

Specialty board-certification context

Estimated specialty board-certified rate — Pulmonary Disease Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pulmonary Disease Physician ABMS/AOA estimate

Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pulmonary Disease Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RAFFI CALIKYAN, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 580 METACOM AVE, BRISTOL, RI, 02809, with a listed phone of (401) 253-0025. NPI 1417063603 was issued on 08/22/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CALIKYAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 5,741 prescription claims written by this provider, covering 633 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 41% brand-name and 59% generic by claim count, with an opioid prescribing rate of 1.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

580 METACOM AVE
BRISTOL, RI 02809

Provider Details

NPI 1417063603
Specialty Pulmonary Disease Physician
Credentials M.D.
Gender Male
NPI Issued 08/22/2006

Hospital and facility affiliations

Facilities where RAFFI CALIKYAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ATWOOD MEDICAL ASSOCIATES LTD
JOHNSTON, RI

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for RAFFI CALIKYAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$2.5K

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

RAFFI CALIKYAN, M.D. — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 5,741 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

5,741
Total Claims
$1.3M
Total Drug Cost
633
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
9,366
Total Day Supply
268,194
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$1.2M
Generic Drug Cost
$107K
Opioid Claims
85 (1.5% rate)
Antibiotic Claims
177

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
1.73
Gender Split
59% female / 41% male
Age Distribution
<65: 56, 65-74: 274, 75-84: 219, 85+: 84

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RAFFI CALIKYAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Trelegy Ellipta
Fluticasone/Umeclidin/Vilanter
602
Albuterol Sulfate Hfa
Albuterol Sulfate
472
Breo Ellipta
Fluticasone/Vilanterol
217
Montelukast Sodium
214
Prednisone
198
Ventolin Hfa
Albuterol Sulfate
198
Fluticasone Propionate
151
Anoro Ellipta
Umeclidinium Brm/Vilanterol Tr
150
Atorvastatin Calcium
137
Furosemide
137

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pulmonary Disease Physician Overview

How RAFFI CALIKYAN, M.D. fits within the Pulmonary Disease Physician landscape nationally.

9,271
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,457
Avg Claims per Provider

RAFFI CALIKYAN, M.D.'s 5,741 claims are above the specialty average of 1,457.

Nearby Pulmonary Disease Physician Providers in Rhode Island

Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as CALIKYAN.

Compare Pulmonary Disease Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RAFFI CALIKYAN, M.D.'s specialty?
RAFFI CALIKYAN, M.D. specializes in Pulmonary Disease Physician and practices in BRISTOL, Rhode Island. Credentials: M.D..
How much does RAFFI CALIKYAN, M.D. prescribe under Medicare Part D?
In 2023, RAFFI CALIKYAN, M.D. wrote 5,741 Medicare Part D claims totaling $1.3M in drug costs for 633 beneficiaries.
Where is RAFFI CALIKYAN, M.D. located?
RAFFI CALIKYAN, M.D. is located at 580 METACOM AVE, BRISTOL, RI, 02809. Phone: (401) 253-0025.
What is RAFFI CALIKYAN, M.D.'s NPI number?
RAFFI CALIKYAN, M.D.'s National Provider Identifier (NPI) is 1417063603, issued on 08/22/2006.
Does RAFFI CALIKYAN, M.D. prescribe more brand-name or generic drugs?
RAFFI CALIKYAN, M.D.'s prescribing is 41% brand-name and 59% generic drugs by claim count, with $1.2M in brand drug costs.
Does RAFFI CALIKYAN, M.D. prescribe opioids?
Yes, RAFFI CALIKYAN, M.D. had 85 opioid claims in 2023 with an opioid prescribing rate of 1.5%.
How many Pulmonary Disease Physician providers are there in the US?
There are 9,271 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,457 Medicare Part D claims per year.
What drugs does RAFFI CALIKYAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, RAFFI CALIKYAN, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Breo Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RAFFI CALIKYAN, M.D. accept Medicare?
RAFFI CALIKYAN, M.D. appears in CMS Medicare data with 5,741 Part D claims and 633 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RAFFI CALIKYAN, M.D.'s credentials?
RAFFI CALIKYAN, M.D.'s NPI is 1417063603 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology